• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

PROCHLORPERAZINE Drug Record

  • Summary
  • Interactions
  • Claims
  • PROCHLORPERAZINE chembl:CHEMBL728 Approved

    Alternate Names:

    COMPRO
    STEMETIL EFF
    PROCHLORPERAZINE MESILATE
    COMPAZINE
    PROCHLORPERAZINE
    PROCLOPERAZINE
    PROCHLORPÉRAZINE
    EMETIRAL
    PROCHLORPERAZINE EDISYLATE
    2-CHLORO-10-(3-(4-METHYL-1-PIPERAZINYL)PROPYL)PHENOTHIAZINE
    PROCLORPERAZINA
    2-CHLORO-10-(3-(1-METHYL-4-PIPERAZINYL)PROPYL)-PHENOTHIAZINE
    PROCHLORPROMAZINE
    BUCCASTEM®
    CHLORMEPRAZINE
    PROCHLORPERAZINUM
    CAPAZINE
    PROCHLORPERMAZINE
    PROCHLORPERAZINE MALEATE
    COMPAZINE®
    CHLORO-3 (N-METHYLPIPERAZINYL-3 PROPYL)-10 PHENOTHIAZINE
    3-CHLORO-10-(3-(1-METHYL-4-PIPERAZINYL)PROPYL)PHENOTHIAZINE
    N-(GAMMA-(4'-METHYLPIPERAZINYL-1')PROPYL)-3-CHLOROPHENOTHIAZINE
    PROCHLORPERAZIN
    3-CHLORO-10-(3-(4-METHYL-1-PIPERAZINYL)PROPYL)PHENOTHIAZINE
    CHLOROPERNAZINE
    chembl:CHEMBL728
    drugbank:00433
    rxcui:8704
    pubchem.compound:4917
    chemidplus:58-38-8

    Drug Info:

    Year of Approval 1956
    Drug Class antipsychotic agents
    Drug Class antiemetics
    Drug Class small molecule
    Drug Indications antiemetic
    FDA Approval approved
    Drug Class Small Molecule
    Drug Indications antimigraine agent
    (4 More Sources)

    Publications:

    Tashiro M et al., 2014, Impact of genetic and non-genetic factors on clinical responses to prochlorperazine in oxycodone-treated cancer patients., Clin Chim Acta
    Callan et al., 2008, Prochlorperazine vs. promethazine for headache treatment in the emergency department: a randomized controlled trial., J Emerg Med
    Vinson, 2006, Development of a simplified instrument for the diagnosis and grading of akathisia in a cohort of patients receiving prochlorperazine., J Emerg Med
    Roberge, 2006, Antiemetic-related dystonic reaction unmasked by removal of a scopolamine transdermal patch., J Emerg Med
    Chen et al., 2002, TTD: Therapeutic Target Database., Nucleic Acids Res.
    Narita et al., 2008, Suppression of dopamine-related side effects of morphine by aripiprazole, a dopamine system stabilizer., Eur. J. Pharmacol.
    Hamik et al., 1989, Differential interactions of traditional and novel antiemetics with dopamine D2 and 5-hydroxytryptamine3 receptors., Cancer Chemother. Pharmacol.
    Golembiewski et al., 2006, Pharmacological prophylaxis and management of adult postoperative/postdischarge nausea and vomiting., J. Perianesth. Nurs.
    Alex et al., 1995, Compatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: evaluation of three methods., Am J Health Syst Pharm
    Sakatis MZ et al., 2012, Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds., Chem Res Toxicol
    Isah AO et al., 1991, Clinical pharmacology of prochlorperazine in healthy young males., Br J Clin Pharmacol
  • PROCHLORPERAZINE   ANKK1

    Interaction Score: 0.47

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    24360851


    Sources:
    PharmGKB

  • PROCHLORPERAZINE   DRD2

    Interaction Score: 0.22

    Interaction Types & Directionality:
    antagonist (inhibitory)

    Interaction Info:
    Trial Name AZ-001, Staccato prochlorperazine
    Novel drug target Established target
    Trial Name buccal prochlorperazine maleate,Emezine

    PMIDs:
    24360851 18534808 17044574 16677982 11752352 18955042 2527092 17169748


    Sources:
    TdgClinicalTrial ChemblInteractions TEND PharmGKB TTD

  • PROCHLORPERAZINE   IL2

    Interaction Score: 0.18

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    8564607


    Sources:
    NCI

  • PROCHLORPERAZINE   RAPGEF4

    Interaction Score: 0.06

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • PROCHLORPERAZINE   MCL1

    Interaction Score: 0.06

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • PROCHLORPERAZINE   HRH1

    Interaction Score: 0.04

    Interaction Types & Directionality:
    antagonist (inhibitory)

    Interaction Info:

    PMIDs:
    1768559


    Sources:
    TEND

  • PROCHLORPERAZINE   HTR2A

    Interaction Score: 0.03

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    TEND

  • PROCHLORPERAZINE   MPHOSPH8

    Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • PROCHLORPERAZINE   DRD1

    Interaction Score: 0.02

    Interaction Types & Directionality:
    antagonist (inhibitory)

    Interaction Info:

    PMIDs:
    None found


    Sources:
    TEND

  • PROCHLORPERAZINE   CBX1

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • PROCHLORPERAZINE   CYP2C9

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22931300


    Sources:
    DTC

  • PROCHLORPERAZINE   CYP2C19

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22931300


    Sources:
    DTC

  • PROCHLORPERAZINE   ATXN2

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • PROCHLORPERAZINE   CYP2D6

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22931300


    Sources:
    DTC

  • PROCHLORPERAZINE   BAZ2B

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • PROCHLORPERAZINE   TP53

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • PROCHLORPERAZINE   IDH1

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • PROCHLORPERAZINE   KDM4A

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • PROCHLORPERAZINE   CYP3A4

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22931300


    Sources:
    DTC

  • PROCHLORPERAZINE   GMNN

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • PROCHLORPERAZINE   CYP1A2

    Interaction Score: 0.0

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • PROCHLORPERAZINE   EHMT2

    Interaction Score: 0.0

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • TEND: PROCHLORPERAZINE

    • Version: 01-August-2011

    Alternate Names:
    PROCHLORPERAZINE Primary Drug Name

    Drug Info:
    Drug Class antiemetics
    Drug Class antipsychotic agents
    Year of Approval 1956

    Publications:

  • TdgClinicalTrial: PROCHLORPERAZINE

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antimigraine agent
    Drug Class Small Molecule
    FDA Approval approved

    Publications:

  • DTC: PROCHLORPERAZINE

    • Version: 02-September-2020

    Alternate Names:
    CHEMBL728 ChEMBL Drug ID

    Drug Info:

    Publications:
    Sakatis MZ et al., 2012, Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds., Chem Res Toxicol

  • NCI: PROCHLORPERAZINE

    • Version: 14-September-2017

    Alternate Names:
    C774 NCI drug code

    Drug Info:

    Publications:
    Alex et al., 1995, Compatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: evaluation of three methods., Am J Health Syst Pharm

  • PharmGKB: prochlorperazine

    • Version: 18-August-2020

    Alternate Names:

    Drug Info:

    Publications:
    Tashiro M et al., 2014, Impact of genetic and non-genetic factors on clinical responses to prochlorperazine in oxycodone-treated cancer patients., Clin Chim Acta

  • TTD: Prochlorperazine

    • Version: 2020.06.01

    Alternate Names:
    D0B2UZ TTD Drug ID

    Drug Info:

    Publications:

  • ChemblInteractions: CHEMBL728

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL728

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21